Task force weighs recommendations as clinical activity resumes
May 19, 2020
A group of clinical chairs and medical directors at UT Health Physicians, the clinical practice of UT Health San Antonio, has formed a Resumption of Clinical Activity Task Force to recommend measures in the setting of continued social distancing and enhanced infection control.
USAA gifts expand testing, vaccine research at UT Health San Antonio
May 19, 2020
The funding will support COVID-19 vaccine research and expand testing capacity for patients and health care workers.
Texas Public Radio: Meet the army of disease detectives tracking COVID-19
May 19, 2020
School of Nursing student, Talice Nieto, and Dr. Barbara Taylor, associate professor of infectious diseases and assistant dean of the M.D./M.P.H., program, were interviewed about contact tracing for the “Petrie Dish” podcast. Dr. Taylor is the leader o …
KENS 5: USAA donates $6.3 million to local, national organizations to aid in the pandemic
May 19, 2020
USAA’s contributions will support coronavirus vaccine research and treatment efforts through the Southwest Research Institute, Texas Biomedical Research Institute, UT Health San Antonio and UTSA. Read the full story.
KENS 5: Second phase of testing for COVID-19 drug
May 18, 2020
The second phase of the clinical trial being led by Dr. Tom Patterson, chief of the Division of Infectious Diseases, for a COVID-19 treatment. This second phase of the trial follows encouraging results from the initial part of the study, which included …
MedicalXpress: Cancer researchers locate drivers of tumor resistance
May 18, 2020
Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. Read the full story.
Cancer researchers locate drivers of tumor resistance
May 18, 2020
Cancer biologists at the Mays Cancer Center, home to UT Health San Antonio MD Anderson, have identified important drivers that enable tumors to change their behavior and evade anticancer therapies. By studying tumors in cell lines, mice and human sampl …
Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Class of 2020 honored during virtual commencements
May 15, 2020
Nearly 700 students have completed requirements for entry into the health care and research workforce.
UT Health San Antonio holds virtual commencements for Class of 2020
May 15, 2020
UT Health San Antonio’s May commencements are occurring virtually this month in response to the COVID-19 pandemic. Nearly 700 students have completed requirements for entry into the health care and research workforce as physicians, nurses, dentists, he …